US › Healthcare

Milestone Pharmaceuticals Inc (MIST)

US · Healthcare · Biotechnology

$1.17+4.46%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$238,000
Net profit
$-26.1M
Profit YoY
-25.6%
EPS
$-0.20
EPS estimate
$0.19
Net margin
-10,952.1%

EPS came in at -0.20 against a street estimate of 0.19 — a miss of 205.3%.

Key statistics

Market cap
$139.4M
Forward P/E
0.0
P/B
3.83
Book value
$0.27
EPS (TTM)
$-0.64
52-week high
$3.06
52-week low
$1.00
50-day MA
$1.28
200-day MA
$1.76
Beta
0.98

Analyst view

Analysts rate Milestone Pharmaceuticals Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $6.33.

Shareholding

Insiders
0.70%
Institutions
34.63%

Largest institutional holders

FundStake
RTW INVESTMENTS, LLC5.09%
Propel Bio Management LLC3.31%
Simplify Asset Management Inc.2.69%
Two Sigma Investments LLC1.86%
The Goldman Sachs Group Inc1.61%
Marshall Wace Asset Management Ltd1.56%
Millennium Management LLC1.24%
Point72 Asset Management, L.P.0.87%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Milestone Pharmaceuticals Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.